Surface hydrophobic modification of fifth-generation hydroxyl-terminated poly(amidoamine) dendrimers and its effect on biocompatibility and rheology

Materials

Volumn 2, Issue 3, 2009, Pages 883-902

  Hamilton, Paul D ^a,b   Jacobs, Donghui Z ^b   Rapp, Brian ^b   Ravi, Nathan ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

Amphiphilic molecules; Biocompatibility; Dendrimers; Lens crystallins; Rheology; Surface modification

Indexed keywords

AMPHIPHILIC MOLECULES; CRYSTALLINS; HYDROPHOBIC MODIFICATION; MONODISPERSE MACROMOLECULES; POLYAMIDOAMINE DENDRIMERS; STORAGE AND LOSS MODULUS; SURFACE FUNCTIONAL GROUPS; SURFACE HYDROPHOBIC MODIFICATION;

BIOCOMPATIBILITY; DENDRIMERS; ELASTICITY; FUNCTIONAL GROUPS; HYDROPHOBICITY; MEDICAL APPLICATIONS; RHEOLOGY; SURFACE TREATMENT; TISSUE CULTURE; TOXICITY;

FUNCTIONAL POLYMERS;

EID: 77951245496     PISSN: None     EISSN: 19961944     Source Type: Journal    
DOI: 10.3390/ma2030883     Document Type: Article

References (48)

1. Tomalia, D.A. Dendrimer molecules. Sci. Am. 1995, 272, 62-66.
2. Tomalia, D.A. Starburst(R) dendrimers - nanoscopic supermolecules according dendritic rules and principles. Macromol. Symp. 1996, 101, 243-255.
3. Boas, U.; Heegaard, P.M.H. Dendrimers in drug research. Chem. Soc. Rev. 2004, 33, 43-63.
4. Cheng, Y.Y.; Wang, J.R.; Rao, T.L.; He, X.X.; Xu, T.W. Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. Front. Biosci. 2008, 13, 1447-1471.
5. Esfand, R.; Tomalia, D.A. Poly(Amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today 2001, 6, 427-436.
6. Freitas, R.A. What is nanomedicine? Dis. Mon. 2005, 51, 325-341.
7. Kim, Y.; Klutz, A.M.; Jacobson, K.A. Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: Synthesis, characterization, and evaluation of cytotoxicity. Bioconjugate Chem. 2008, 19, 1660-1672.
8. Paleos, C.M.; Tziveleka, L.A.; Sideratou, Z.; Tsiourvas, D. Gene delivery using functional dendritic polymers. Expert Opin. Drug Deliv. 2009, 6, 27-38.
9. Paleos, C.M.; Tsiourvas, D.; Sideratou, Z. Molecular engineering of dendritic polymers and their application as drug and gene delivery systems. Mol. Pharmaceutics 2007, 4, 169-188.
10. Svenson, S.; Tomalia, D.A. Commentary - dendrimers in biomedical applications - reflections on the field. Adv. Drug Delivery Rev. 2005, 57, 2106-2129.
11. Svenson, S. Dendrimers as versatile platform in drug delivery applications. Eur. J. Pharm. Biopharm. 2009, 71, 445-462.
12. Tomalia, D.A.; Reyna, L.A.; Svenson, S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem. Soc. Trans. 2007, 35, 61-67.
13. Duan, X.; Sheardown, H. Dendrimer crosslinked collagen as a corneal tissue engineering scaffold: Mechanical properties and corneal epithelial cell interactions. Biomaterials 2006, 27, 4608-4617.
14. Duan, X.D.; McLaughlin, C.; Griffith, M.; Sheardown, H. Biofunctionalization of collagen for improved biological response: Scaffolds for corneal tissue engineering. Biomaterials 2007, 28, 78-88.
15. Cheng, Y.Y.; Man, N.; Xu, T.W.; Fu, R.Q.; Wang, X.Y.; Wang, X.M. Wen, L.P. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. J. Pharm. Sci. 2007, 96, 595-602.
16. Cheng, Y.Y.; Xu, Z.H.; Ma, M.L.; Xu, T.W. Dendrimers as drug carriers: Applications in different routes of drug administration. J. Pharm. Sci. 2008, 97, 123-143.
17. Vandamme, T.F.; Brobeck, L. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J. Controlled Release 2005, 102, 23-38.
18. Marano, R.J.; Wimmer, N.; Kearns, P.S.; Thomas, B.G.; Toth, I.; Brankov, M.; Rakoczy, P.E. Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide. Exp. Eye Res. 2004, 79, 525-535.
19. Grinstaff, M.W. Designing hydrogel adhesives for corneal wound repair. Biomaterials 2007, 28, 5205-5214.
20. Roberts, J.C.; Bhalgat, M.K.; Zera, R.T. Preliminary biological evaluation of polyamidoamine (PAMAM) starburst(TM) dendrimers. J. Biomed. Mater. Res. 1996, 30, 53-65.
21. Duncan, R.; Izzo, L. Dendrimer biocompatibility and toxicity. Adv. Drug Delivery Rev. 2005, 57, 2215-2237.
22. Dutta, T.; Garg, M.; Dubey, V.; Mishra, D.; Singh, K.; Pandita, D.; Singh, A.K.; Ravi, A.K.; Velpandian, T.; Jain, N.K. Toxicological investigation of surface engineered fifth generation poly (propyleneimine) dendrimers in vivo. Nanotoxicology 2008, 2, 62-70.
23. Jia, L.; Xu, J.P.; Ji, J.; Shen, J.C. Surface engineering of poly(amido-amine) via biomimetic phosphorylcholine [In Chinese]. Acta Polym. Sin. 2008, 1108-1112.
24. Kolhatkar, R.B.; Kitchens, K.M.; Swaan, P.W.; Ghandehari, H. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjugate Chem. 2007, 18, 2054-2060.
25. Kuo, J.H.S.; Jan, M.S.; Chu, H.W. Mechanism of cell death induced by cationic dendrimers in RAW 264.7 murine macrophage-like cells. J. Pharm. Pharmacol. 2005, 57, 489-495.
26. Malik, N.; Wiwattanapatapee, R.; Klopsch, R.; Lorenz, K.; Frey, H.; Weener, J.W.; Meijer, E.W.; Paulus, W.; Duncan, R. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of I-125-Labelled polyamidoamine dendrimers in vivo. J. Controlled Release 2000, 65, 133-148.
27. Satija, J.; Gupta, U.; Jain, N.K. Pharmaceutical and biomedical potential of surface engineered dendrimers. Crit. Rev. Ther. Drug Carrier Syst. 2007, 24, 257-306.
28. Seib, F.P.; Jones, A.T.; Duncan, R. Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells. J. Controlled Release 2007, 117, 291-300.
29. Singh, S.; Nalwa, H.S. Nanotechnology and health safety - toxicity and risk assessments of nanostructured materials on human health. J. Nanosci. Nanotechnol. 2007, 7, 3048-3070.
30. Xiao, Y.C.; Chung, T.S.; Chng, M.L. Surface characterization, modification chemistry, and separation performance of polyimide and polyamidoamine dendrimer composite films. Langmuir 2004, 20, 8230-8238.
31. Yoo, H.; Juliano, R.L. Enhanced delivery of antisense oligonucleotides with fluorophoreconjugated PAMAM dendrimers. Nucleic Acids Res. 2000, 28, 4225-4231.
32. Yoo, H.; Sazani, P.; Juliano, R.L. PAMAM dendrimers as delivery agents for antisense oligonucleotides. Pharm. Res. 1999, 16, 1799-1804.
33. Aliyar, H.; Hamilton, P.D.; Ravi N. Refilling of lens capsular bag with copolymeric hydrogel containing reversible disulfide. Biomacromolecules 2005, 6, 204-211.
34. Ravi, N.; Aliyar, H.A.; Hamilton, P.D. Hydrogel nanocomposite as a synthetic intra-ocular lens capable of accommodation. Macromol. Symp. 2005, 227, 191-201.
35. Ravi, N.; Aliyar, H.A.; Hamilton, P.D. Hybrid hydrogels as potential lens replacement material. Polym. Prepr. 2004, 45, 366.
36. Reilly, M.A.; Rapp, B.; Hamilton, P.D.; Shen, A.Q.; Ravi, N. Material characterization of porcine lenticular soluble proteins. Biomacromolecules 2008, 9, 1519-1526.
37. Rapp, B.; Reilly, M.A.; Hamilton, P.D.; Ravi, N. A comparison of the viscoelastic properties of porcine crystallins and OH terminal PAMAM dendrimers. Polym. Prep. 2006, 47, 62.
38. Zhang, D.H.; Hamilton, P.D.; Ravi, N.; Kao, J.F. Synthesis of amphiphilic hydroxyl terminated poly(amidoamine) dendrimer. Polym.Prepr. 2006, 47, 63.
39. Zhang, D.H.; Hamilton, P.D.; Kao, J.L.F.; Venkataraman, S.; Wooley, K.L.; Ravi, N. Formation of nanogel aggregates by an amphiphilic cholesteryl-poly(amidoamine) dendrimer in aqueous media. J. Polym. Sci. Part A: Polym. Chem. 2007, 45, 2569-2575.
40. Nourse, A.; Millar, D.B.; Minton, A.P. Physicochemical characterization of generation 5 polyamidoamine dendrimers. Biopolymers 2000, 53, 316-328.
41. Tomalia, D.A. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog. Polym. Sci. 2005, 30, 294-324.
42. Uppuluri, S.; Keinath, S.E.; Tomalia, D.A.; Dvornic, P.R. Rheology of dendrimers. I. newtonian flow behavior of medium and highly concentrated solutions of polyamidoamine (PAMAM) dendrimers in ethylenediamine (EDA) solvent. Macromolecules 1998, 31, 4498-4510.
43. Uppuluri, S.; Morrison, F.A.; Dvornic, P.R. Rheology of dendrimers. 2. bulk polyamidoamine dendrimers under steady shear, creep, and dynamic oscillatory shear. Macromolecules 2000, 33, 2551-2560.
44. Dvornic, P.R. A Decade of dendrimer rheology: what have we learned? Polym.Prep. 2001, 221, U365.
45. Dufes, C.; Uchegbu, I.F.; Schatzlein, A.G. Dendrimers in gene delivery. Adv. Drug Delivery Rev. 2005, 57, 2177-2202.
46. Welch, P.; Muthukumar, M. Tuning the density profile of dendritic polyelectrolytes. Macromolecules 1998, 31, 5892-5897.
47. Patri, A.K.; Kukowska-Latallo, J.F.; Baker, J.R. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv. Drug Delivery Rev. 2005, 57, 2203-2214.
48. Liu, C.S.C.; Wormstone, I.M.; Duncan, G.; Marcantonio, J.M.; Webb, S.F.; Davies, P.D. A study of human lens cell growth in vitro - a model for posterior capsule opacification. Invest. Ophthalmol. Vis. Sci. 1996, 37, 906-914.